Generation of multivirus-specific T cells by a single stimulation of peripheral blood mononuclear cells with a peptide mixture using serum-free medium-Reference-Cited by-同舟云学术

Generation of multivirus-specific T cells by a single stimulation of peripheral blood mononuclear cells with a peptide mixture using serum-free medium

Published:2018-09 Issue:9 Volume:20 Page:1182-1190
ISSN:1465-3249
Container-title:Cytotherapy
language:en
Short-container-title:Cytotherapy

Author:

NISHIYAMA-FUJITA YURIKO,KAWANA-TACHIKAWA AI,ONO TOSHIAKI,TANAKA YUKIE,KATO TAKAFUMI,HESLOP HELEN E.,MORIO TOMOHIRO,TAKAHASHI SATOSHI

Funder

Health Labour Sciences Research

Japan Agency for Medical Research and Development Research

Publisher

Elsevier BV

Subject

Cancer Research,Transplantation,Cell Biology,Genetics(clinical),Oncology,Immunology,Immunology and Allergy

Reference24 articles.

1. Donor T cells to treat EBV-associated lymphoma;Heslop;N Engl J Med,1994

2. Long-term outcome of EBV-specific T-cell infusions to prevent or treat EBV-related lymphoproliferative disease in transplant recipients;Heslop;Blood,2010

3. Adoptive immunotherapy with unselected or EBV-specific T cells for biopsy-proven EBV+ lymphomas after allogeneic hematopoietic cell transplantation;Doubrovina;Blood,2012

4. Adoptive cellular therapy for early cytomegalovirus infection after allogeneic stem-cell transplantation with virus-specific T-cell lines;Peggs;Lancet,2003

5. Clinical grade generation of hexon-specific T cells for adoptive T-cell transfer as a treatment of adenovirus infection after allogeneic stem cell transplantation;Feuchtinger;J Immunother,2008

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Advancing Allogeneic Hematopoietic Stem Cell Transplantation Outcomes through Immunotherapy: A Comprehensive Review of Optimizing Non-CAR Donor T-Lymphocyte Infusion Strategies;Biomedicines;2024-08-14

2. Long-Term Follow-Up after Adoptive Transfer of BK-Virus-Specific T Cells in Hematopoietic Stem Cell Transplant Recipients;Vaccines;2023-04-14

3. Generation of good manufacturing practice grade virus-specific T cells for the management of post-transplant CMV infections;Journal of Immunological Methods;2022-12

4. Advances in T-cell Immunotherapies;Hematology/Oncology Clinics of North America;2019-10

5. Breaking Therapy Resistance: An Update on Oncolytic Newcastle Disease Virus for Improvements of Cancer Therapy;Biomedicines;2019-08-30